TAM
Trillium Asset Management’s AstraZeneca AZN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $40.9M | Sell |
585,898
-63,541
| -10% | -$4.44M | 1.1% | 23 |
|
2025
Q1 | $47.7M | Sell |
649,439
-19,252
| -3% | -$1.42M | 1.37% | 12 |
|
2024
Q4 | $43.8M | Sell |
668,691
-33,232
| -5% | -$2.18M | 1.14% | 17 |
|
2024
Q3 | $54.7M | Sell |
701,923
-11,320
| -2% | -$882K | 1.34% | 12 |
|
2024
Q2 | $55.6M | Sell |
713,243
-26,952
| -4% | -$2.1M | 1.4% | 13 |
|
2024
Q1 | $50.1M | Buy |
740,195
+6,985
| +1% | +$473K | 1.28% | 16 |
|
2023
Q4 | $49.4M | Sell |
733,210
-18,893
| -3% | -$1.27M | 1.35% | 14 |
|
2023
Q3 | $50.9M | Sell |
752,103
-3,650
| -0.5% | -$247K | 1.53% | 10 |
|
2023
Q2 | $54.1M | Sell |
755,753
-123,183
| -14% | -$8.82M | 1.52% | 9 |
|
2023
Q1 | $64.2M | Buy |
878,936
+40,117
| +5% | +$2.93M | 1.88% | 5 |
|
2022
Q4 | $56.9M | Buy |
838,819
+19,544
| +2% | +$1.33M | 1.75% | 7 |
|
2022
Q3 | $44.9M | Buy |
819,275
+39,290
| +5% | +$2.15M | 1.47% | 9 |
|
2022
Q2 | $51.5M | Buy |
779,985
+75,415
| +11% | +$4.98M | 1.58% | 7 |
|
2022
Q1 | $46.7M | Buy |
704,570
+43,850
| +7% | +$2.91M | 1.24% | 17 |
|
2021
Q4 | $38.5M | Buy |
660,720
+25,662
| +4% | +$1.49M | 0.9% | 35 |
|
2021
Q3 | $38.1M | Buy |
635,058
+14,470
| +2% | +$869K | 1.01% | 29 |
|
2021
Q2 | $37.1M | Buy |
620,588
+56,494
| +10% | +$3.38M | 1.03% | 26 |
|
2021
Q1 | $28M | Buy |
564,094
+57,856
| +11% | +$2.88M | 0.89% | 40 |
|
2020
Q4 | $25.3M | Buy |
506,238
+43,112
| +9% | +$2.16M | 0.91% | 36 |
|
2020
Q3 | $25.4M | Sell |
463,126
-26,480
| -5% | -$1.45M | 1.07% | 29 |
|
2020
Q2 | $25.9M | Buy |
489,606
+53,856
| +12% | +$2.85M | 1.11% | 25 |
|
2020
Q1 | $19.5M | Buy |
435,750
+264,373
| +154% | +$11.8M | 1.02% | 27 |
|
2019
Q4 | $8.55M | Buy |
171,377
+10,218
| +6% | +$509K | 0.38% | 94 |
|
2019
Q3 | $7.18M | Buy |
+161,159
| New | +$7.18M | 0.34% | 99 |
|